Clinical Trial Update: Acute Effects of Inhaled Treprostinil in Fontan Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on the acute effects of inhaled treprostinil in Fontan patients with congenital heart disease; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Treprostinil (treprostinil)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Congenital Heart Disease | Phase 2 | Status: TERMINATED | Results posted: 2020-07-29